Reaction
Cytomegalovirus Gastritis reporting signals
As of the last recalculation, Cytomegalovirus Gastritis appears in 242 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is GANCICLOVIR SODIUM (PRR 354.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ganciclovir Sodium | 37 | 354.8 | 356.1 |
| Ganciclovir | 35 | 343.7 | 344.9 |
| Valganciclovir Hydrochloride Powder, | 29 | 232.2 | 232.8 |
| Valganciclovir | 34 | 180.3 | 180.6 |
| Valganciclovir Hydrochloride | 34 | 180.3 | 180.6 |
| Everolimus Tablets | 21 | 117.9 | 118.0 |
| Basiliximab | 15 | 116.9 | 117.0 |
| Tacrolimus Ointment 0.1% | 86 | 91.6 | 91.7 |
| Tacrolimus Extended-Release Capsules | 86 | 91.3 | 91.4 |
| Busulfan | 8 | 45.2 | 45.2 |